English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
新光維醫療與上海市第一婦嬰保健院簽訂戰略合作協定,共同建立婦科內鏡診療聯合創新中心
Nov 14, 2022 16:11 HKT
新光维医疗与上海市第一妇婴保健院签订战略合作协议,共同建立妇科内镜诊疗联合创新中心
Nov 14, 2022 16:10 HKT
InaVac gets emergency approval from BPOM
Nov 14, 2022 11:30 HKT
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again
Nov 14, 2022 08:59 HKT
Novotech, 동서 MRCT 전략 구축 및 자금 조달 방법에 대한 바이오 센추리 정상회담 워크숍 의장
Nov 12, 2022 14:00 HKT
Novotech 主持关于如何建立和资助东西方 MRCT 战略的 BioCentury 峰会研讨会
Nov 12, 2022 08:00 HKT
Novotech 主持關於如何建立和資助東西方 MRCT 戰略的 BioCentury 峰會研討會
Nov 12, 2022 08:00 HKT
Healthcare and Medical Leaders Gather to Shape the Future of Global Health
Nov 11, 2022 20:00 HKT
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Nov 11, 2022 17:00 HKT
Prenetics 2022年第三季度财务业绩创纪录 上调2022年全年收入及经调整税息折旧及摊销前利润指引
Nov 10, 2022 21:38 HKT
Prenetics 2022年第三季度財務業績創紀錄 上調2022年全年收入及經調整稅息折舊及攤銷前利潤指引
Nov 10, 2022 21:37 HKT
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Nov 10, 2022 21:36 HKT
Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair
Nov 10, 2022 18:00 HKT
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Nov 10, 2022 14:26 HKT
Bintai Kinden Ventures into Telco through Agreement with MN Permai Netcom
Nov 10, 2022 13:00 HKT
新光維醫療攜手富士膠片歐洲,打開歐洲主要國家市場
Nov 08, 2022 09:39 HKT
新光维医疗携手富士胶片欧洲,打开欧洲主要国家市场
Nov 08, 2022 09:38 HKT
新股上市 心泰医疗(2291.HK)今日于港交所上市 暗盘收涨2.23%
Nov 08, 2022 08:56 HKT
新股上市 心泰醫療(2291.HK)今日於港交所上市 暗盤收漲2.23%
Nov 08, 2022 08:55 HKT
Sirnaomics已完成STP705用于成人腹部减脂医学美容治疗的首例受试者给药
Nov 08, 2022 08:45 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: